{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T18:29:31Z","timestamp":1759775371992,"version":"3.40.5"},"reference-count":24,"publisher":"Elsevier BV","content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Immunological Methods"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1016\/j.jim.2014.03.004","type":"journal-article","created":{"date-parts":[[2014,3,17]],"date-time":"2014-03-17T05:26:26Z","timestamp":1395033986000},"page":"131-136","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Common consensus LNA probe for quantitative PCR assays in cancer: Vehicles for minimal residual disease detection in t(11;14) and t(14;18) positive malignant lymphomas"],"prefix":"10.1016","volume":"406","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7170-2734","authenticated-orcid":false,"given":"Camilla Darum","family":"S\u00f8rensen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9784-2703","authenticated-orcid":false,"given":"Judit Meszaros","family":"J\u00f8rgensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Line","family":"Nederby","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Hokland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charlotte Guldborg","family":"Nyvold","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jim.2014.03.004_bb0115","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.3324\/haematol.2008.004267","article-title":"How and why minimal residual disease studies are necessary in leukemia: a review from WP10 and WP12 of the European LeukaemiaNet","volume":"94","author":"Bene","year":"2009","journal-title":"Haematologica"},{"key":"10.1016\/j.jim.2014.03.004_bb0110","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1016\/j.ejca.2012.11.010","article-title":"Minimal residual disease after induction is the strongest predictor of prognosis in intermediate risk relapsed acute lymphoblastic leukaemia\u2014long-term results of trial ALL-REZ BFM P95\/96","volume":"49","author":"Eckert","year":"2013","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.jim.2014.03.004_bb0095","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/hon.989","article-title":"Minimal residual disease detection in lymphoma and multiple myeloma: impact on therapeutic paradigms","volume":"29","author":"Ferrero","year":"2011","journal-title":"Hematol. Oncol."},{"key":"10.1016\/j.jim.2014.03.004_bb0030","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1038\/sj.leu.2403135","article-title":"Standardization and quality control studies of 'real-time' quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia\u2014a Europe Against Cancer program","volume":"17","author":"Gabert","year":"2003","journal-title":"Leukemia"},{"key":"10.1016\/j.jim.2014.03.004_bb0120","doi-asserted-by":"crossref","first-page":"3800","DOI":"10.1182\/blood.V83.12.3800.3800","article-title":"Detection of residual lymphoma cells by polymerase chain reaction in peripheral blood is significantly less predictive for relapse than detection in bone marrow","volume":"83","author":"Gribben","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.jim.2014.03.004_bb0020","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1097\/CCO.0b013e32833ed831","article-title":"Assessment of minimal residual disease in acute myeloid leukemia","volume":"22","author":"Grimwade","year":"2010","journal-title":"Curr. Opin. Oncol."},{"key":"10.1016\/j.jim.2014.03.004_bb0075","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1182\/blood-2004-02-0738","article-title":"Low prevalence of circulating t(11;14)(q13;q32)-positive cells in the peripheral blood of healthy individuals as detected by real-time quantitative PCR","volume":"104","author":"Hirt","year":"2004","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.jim.2014.03.004_bb0090","doi-asserted-by":"crossref","first-page":"2678","DOI":"10.3109\/10428194.2013.788177","article-title":"Circulating t(14;18)-positive cells in healthy individuals: association with age and sex but not with smoking","volume":"54","author":"Hirt","year":"2013","journal-title":"Leuk. Lymphoma"},{"year":"2011","author":"Hoffbrand","series-title":"Essential Haematology","key":"10.1016\/j.jim.2014.03.004_bb0005"},{"key":"10.1016\/j.jim.2014.03.004_bb0015","doi-asserted-by":"crossref","first-page":"3416","DOI":"10.1172\/JCI61272","article-title":"Molecular pathogenesis of mantle cell lymphoma","volume":"122","author":"Jares","year":"2012","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jim.2014.03.004_bb0055","doi-asserted-by":"crossref","first-page":"2778","DOI":"10.1021\/jo972239c","article-title":"Synthesis of novel 2',3'-linked bicyclic thymine ribonucleosides","volume":"63","author":"Koshkin","year":"1998","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.jim.2014.03.004_bb0100","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1177\/2040620713480522","article-title":"Clinical implications and prognostic role of minimal residual disease detection in follicular lymphoma","volume":"4","author":"Lobetti-Bodoni","year":"2013","journal-title":"Ther. Adv. Hematol."},{"key":"10.1016\/j.jim.2014.03.004_bb0025","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/hon.792","article-title":"Monitoring minimal residual disease and controlling drug resistance in chronic myeloid leukaemia patients in treatment with imatinib as a guide to clinical management","volume":"24","author":"Martinelli","year":"2006","journal-title":"Hematol. Oncol."},{"key":"10.1016\/j.jim.2014.03.004_bb0060","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1038\/sj.leu.2401575","article-title":"Real-time t(11;14) and t(14;18) PCR assays provide sensitive and quantitative assessments of minimal residual disease (MRD)","volume":"13","author":"Olsson","year":"1999","journal-title":"Leukemia"},{"key":"10.1016\/j.jim.2014.03.004_bb0040","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/978-1-62703-269-8_10","article-title":"MRD detection in B-cell non-Hodgkin lymphomas using Ig gene rearrangements and chromosomal translocations as targets for real-time quantitative PCR","volume":"971","author":"Pott","year":"2013","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.jim.2014.03.004_bb0035","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1146\/annurev-pathol-020712-164004","article-title":"Chromosome translocation, B cell lymphoma, and activation-induced cytidine deaminase","volume":"8","author":"Robbiani","year":"2013","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.jim.2014.03.004_bb0080","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.leukres.2005.10.001","article-title":"The bcl-2\/IgH rearrangement in a population of 204 healthy individuals: occurrence, age and gender distribution, breakpoints, and detection method validity","volume":"30","author":"Schmitt","year":"2006","journal-title":"Leuk. Res."},{"key":"10.1016\/j.jim.2014.03.004_bb0085","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1002\/ijc.23958","article-title":"Prevalence and frequency of circulating t(14;18)-MBR translocation carrying cells in healthy individuals","volume":"124","author":"Schuler","year":"2009","journal-title":"Int. J. Cancer"},{"issue":"1","key":"10.1016\/j.jim.2014.03.004_bb0105","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1182\/blood-2012-10-461749","article-title":"The level of residual disease based on mutant NPM1 is an independent prognostic factor for relapse and survival in AML","volume":"122","author":"Shayegi","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.jim.2014.03.004_bb0065","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1373\/clinchem.2009.132951","article-title":"Detection of increased amounts of cell-free fetal DNA with short PCR amplicons","volume":"56","author":"Sikora","year":"2010","journal-title":"Clin. Chem."},{"year":"2008","author":"Swerdlow","series-title":"WHO classification of tumours of haematopoietic and lymphoid tissues","key":"10.1016\/j.jim.2014.03.004_bb0010"},{"key":"10.1016\/j.jim.2014.03.004_bb0070","doi-asserted-by":"crossref","first-page":"33","DOI":"10.2209\/tdcpublication.45.33","article-title":"Influence of template DNA degradation on the genotyping of SNPs and STR polymorphisms from forensic materials by PCR","volume":"45","author":"Utsuno","year":"2004","journal-title":"Bull. Tokyo Dent. Coll."},{"key":"10.1016\/j.jim.2014.03.004_bb0045","doi-asserted-by":"crossref","first-page":"530","DOI":"10.2353\/jmoldx.2007.070038","article-title":"''Minor'' BCL2 breakpoints in follicular lymphoma: frequency and correlation with grade and disease presentation in 236 cases","volume":"9","author":"Weinberg","year":"2007","journal-title":"J. Mol. Diagn."},{"key":"10.1016\/j.jim.2014.03.004_bb0050","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1182\/blood.V78.2.493.493","article-title":"Rearrangement of the chromosome 11 bcl-1 locus in centrocytic lymphoma: analysis with multiple breakpoint probes","volume":"78","author":"Williams","year":"1991","journal-title":"Blood"}],"container-title":["Journal of Immunological Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022175914000787?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022175914000787?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,16]],"date-time":"2020-08-16T10:08:00Z","timestamp":1597572480000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022175914000787"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4]]},"references-count":24,"alternative-id":["S0022175914000787"],"URL":"https:\/\/doi.org\/10.1016\/j.jim.2014.03.004","relation":{},"ISSN":["0022-1759"],"issn-type":[{"type":"print","value":"0022-1759"}],"subject":[],"published":{"date-parts":[[2014,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Common consensus LNA probe for quantitative PCR assays in cancer: Vehicles for minimal residual disease detection in t(11;14) and t(14;18) positive malignant lymphomas","name":"articletitle","label":"Article Title"},{"value":"Journal of Immunological Methods","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jim.2014.03.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}